zdorПроблемы здоровья и экологииHealth and Ecology Issues2220-09672708-6011Gomel State Medical University10.51523/2708-6011.2010-7-1-3zdor-906Research ArticleКЛИНИЧЕСКАЯ МЕДИЦИНАCLINICAL MEDICINEОСТРЫЙ КОРОНАРНЫЙ СИНДРОМ: СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ ТЕРАПИИ (обзор литературы, часть II)THE ACUTE CORONARY SYNDROME : POSSIBILITY ON THE MODERN THERAPY (literature review. Part II)СаливончикД. П.SalivonchikD. P.noemail@neicon.ruГомельский областной клинический кардиологический диспансерGomel Regional Clinical Cardial Dinspensary201028032010011319Copyright © Саливончик Д.П., 20102010Саливончик Д.П.Salivonchik D.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.gsmu.by/jour/article/view/906

В обзоре представлена информация о современной медикаментозной и инструментальной терапии острого коронарного синдрома (ОКС).

The information about the modern medical treatment of the acute coronary syndrome was presented in this review

острый коронарный синдроминфаркт миокарданестабильная стенокардияacute coronary syndromemyocardial infarctionunstable anginaReferencesValue of first day angiography/angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicenter randomized trial (The VINO study) / R. Spacer [et al.] // Eur. Heart J. - 2002. - Vol. 23. - P. 230-238.Value of first day angiography/angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicenter randomized trial (The VINO study) / R. Spacer [et al.] // Eur. Heart J. - 2002. - Vol. 23. - P. 230-238.Routine vs. selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trial / S. R. Mehta [et al.] // J.A.M.A. - 2005. - Vol. 293. - P. 2908-2917.Routine vs. selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trial / S. R. Mehta [et al.] // J.A.M.A. - 2005. - Vol. 293. - P. 2908-2917.Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group Low-molecular-weight heparin during instability in coronary artery disease // Lancet. - 1996. - Vol. 347. - P. 561-568.Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group Low-molecular-weight heparin during instability in coronary artery disease // Lancet. - 1996. - Vol. 347. - P. 561-568.Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE 2 study The Antithrombotic Combination Using Tirofiban and Enoxapation / M. Cohen [et al.] // Am. Heart J. - 2002. - Vol. 144. - P. 470-477.Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE 2 study The Antithrombotic Combination Using Tirofiban and Enoxapation / M. Cohen [et al.] // Am. Heart J. - 2002. - Vol. 144. - P. 470-477.The F.R.A.X.I.S. Study Group Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S.(FRAxiparine in Ischemic Syndrome) // Eur. Heart J. - 1999. - Vol. 20. - P. 1553-1562.The F.R.A.X.I.S. Study Group Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S.(FRAxiparine in Ischemic Syndrome) // Eur. Heart J. - 1999. - Vol. 20. - P. 1553-1562.The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes / N. Engl. J. Med. - 1996. - Vol. 335. - P. 775-782.The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes / N. Engl. J. Med. - 1996. - Vol. 335. - P. 775-782.Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: result of the Thrombolysis In Myocardial Infarction (TIMI) IIB trial / E. M. Antman [et al.] // Circulation. - 1999. - Vol. 100. - P. 1593-1601.Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: result of the Thrombolysis In Myocardial Infarction (TIMI) IIB trial / E. M. Antman [et al.] // Circulation. - 1999. - Vol. 100. - P. 1593-1601.Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial / J. J. Ferguson [et al.] // J.A.M.A. - 2004. - Vol. 292. - P. 45-54.Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial / J. J. Ferguson [et al.] // J.A.M.A. - 2004. - Vol. 292. - P. 45-54.Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview / J. L. Petersen [et al.] // J.A.M.A. - 2004. - Vol. 292. - P. 89-96.Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview / J. L. Petersen [et al.] // J.A.M.A. - 2004. - Vol. 292. - P. 89-96.For the ExTRACT-TIMI 25 Investigators. Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction / E. M. Antman [et al.] // N. Engl. J. Med. - 2006. - Vol. 354. - P. 1477-1488.For the ExTRACT-TIMI 25 Investigators. Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction / E. M. Antman [et al.] // N. Engl. J. Med. - 2006. - Vol. 354. - P. 1477-1488.Evaluation of prolonged antithrombotic pretreatment («cooling-off» strategy) before intervention in patients with unstable coronary syndromes a randomized controlled trial / F. J. Neumann [et al.] // J.A.M.A. - 2003. - Vol. 290. - P. 1593-1599.Evaluation of prolonged antithrombotic pretreatment («cooling-off» strategy) before intervention in patients with unstable coronary syndromes a randomized controlled trial / F. J. Neumann [et al.] // J.A.M.A. - 2003. - Vol. 290. - P. 1593-1599.Efficacy and Safety of Subcutaneous Enoxaparin in NON-Q-Wave Coronary Events Study Group A comparison of Low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease / M. Cohen [et al.] // N. Engl. J. Med. - 1997. - Vol. 337. - P. 447-452.Efficacy and Safety of Subcutaneous Enoxaparin in NON-Q-Wave Coronary Events Study Group A comparison of Low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease / M. Cohen [et al.] // N. Engl. J. Med. - 1997. - Vol. 337. - P. 447-452.Comparison of fondaparinux and enoxaparin in acute coronary syndromes / S. Yusuf [et al.] // N. Engl. J. Med. - 2006. - Vol. 354. - P. 1464-1476.Comparison of fondaparinux and enoxaparin in acute coronary syndromes / S. Yusuf [et al.] // N. Engl. J. Med. - 2006. - Vol. 354. - P. 1464-1476.PRISM Study Investigators Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban Platelet receptor Inhibition in Ischemic Syndrome Management / C. Heeschen [et al.] // Lancet. - 1999. - Vol. 354. - P. 1757-1762.PRISM Study Investigators Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban Platelet receptor Inhibition in Ischemic Syndrome Management / C. Heeschen [et al.] // Lancet. - 1999. - Vol. 354. - P. 1757-1762.Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial / A. Kastrati [et al.] // J.A.M.A. - 2006. - Vol. 295. - P. 1531-1538.Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial / A. Kastrati [et al.] // J.A.M.A. - 2006. - Vol. 295. - P. 1531-1538.The platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network (PARAGON)-B Investigators Randomized, placebo-controlled trial of titrated intravenous lamifiban for the acute coronary syndromes // Circulation. - 2002. - Vol. 105. - P. 316-321.The platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network (PARAGON)-B Investigators Randomized, placebo-controlled trial of titrated intravenous lamifiban for the acute coronary syndromes // Circulation. - 2002. - Vol. 105. - P. 316-321.Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience / M. W. McClure [et al.] // Circulation. - 1999. - Vol. 99. - P. 2892-2900.Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience / M. W. McClure [et al.] // Circulation. - 1999. - Vol. 99. - P. 2892-2900.The CAPTURE Investigators Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study // Lancet. - 1997. - Vol. 349. - P. 1429-1435.The CAPTURE Investigators Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study // Lancet. - 1997. - Vol. 349. - P. 1429-1435.Simons, M. L. Effect of glycoprotein IIb/IIIa receptor locker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularization: the GUSTO IV-ACS randomized trial / M. L. Simons // Lancet. - 2001. - Vol. 357. - P. 1915-1924.Simons, M. L. Effect of glycoprotein IIb/IIIa receptor locker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularization: the GUSTO IV-ACS randomized trial / M. L. Simons // Lancet. - 2001. - Vol. 357. - P. 1915-1924.The EPISTENT Investigators Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade Evaluation of Platelet IIb/IIIa Inhibitor for Stenting // Lancet. - 1998. - Vol. 352. - P. 87-92.The EPISTENT Investigators Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade Evaluation of Platelet IIb/IIIa Inhibitor for Stenting // Lancet. - 1998. - Vol. 352. - P. 87-92.Routine upstream initiation vs. deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. The ACUITY Timing Trial / G. Stone [et al.] // J.A.M.A. - 2007. - Vol. 297. - P. 591-602.Routine upstream initiation vs. deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. The ACUITY Timing Trial / G. Stone [et al.] // J.A.M.A. - 2007. - Vol. 297. - P. 591-602.Antman, E. M. Hirudin in acute myocardial infarction: safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial / E. M. Antman // Circulation. - 1994. - Vol. 90. - P. 1624-1630.Antman, E. M. Hirudin in acute myocardial infarction: safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial / E. M. Antman // Circulation. - 1994. - Vol. 90. - P. 1624-1630.Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators Effects of recombinant hirudin (Lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularization procedures in patients with acute myocardial ischemia without ST elevation: a randomized trial // Lancet. - 1999. - Vol. 353. - P. 429-438.Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators Effects of recombinant hirudin (Lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularization procedures in patients with acute myocardial ischemia without ST elevation: a randomized trial // Lancet. - 1999. - Vol. 353. - P. 429-438.Bivalirudin for patients with acute coronary syndromes / G. W. Stone [et al.] // N. Engl. J. Med. - 2006. - Vol. 355. - P. 2203-2216.Bivalirudin for patients with acute coronary syndromes / G. W. Stone [et al.] // N. Engl. J. Med. - 2006. - Vol. 355. - P. 2203-2216.Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis / S. S. Anand [et al.] / J.A.M.A. - 1999. - Vol. 282. - P. 2058-2067.Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis / S. S. Anand [et al.] / J.A.M.A. - 1999. - Vol. 282. - P. 2058-2067.Department of Veterans Affairs Cooperative Studies Program clinical trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study / L. D. Fiore [et al.] / Circulation. - 2002. - Vol. 105. - P. 557-563.Department of Veterans Affairs Cooperative Studies Program clinical trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study / L. D. Fiore [et al.] / Circulation. - 2002. - Vol. 105. - P. 557-563.Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force / M. Hayden [at al.] // Ann. Intern. Med. - 2002. - Vol. 136. - P. 161-172.Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force / M. Hayden [at al.] // Ann. Intern. Med. - 2002. - Vol. 136. - P. 161-172.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation / S. Yusuf [et al.] // N. Engl. J. Med. - 2001. - Vol. 345. - P. 494-502.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation / S. Yusuf [et al.] // N. Engl. J. Med. - 2001. - Vol. 345. - P. 494-502.Optimal timing of coronary artery bypass graft surgery after acute myocardial infarction / J. H. Braxton [et al.] // Circulation. - 1995. - Vol. 92. - P. 66-68.Optimal timing of coronary artery bypass graft surgery after acute myocardial infarction / J. H. Braxton [et al.] // Circulation. - 1995. - Vol. 92. - P. 66-68.Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding / F. K. Chan [et al.] // N. Engl. J. Med. - 2005. - Vol. 532. - P. 238-244.Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding / F. K. Chan [et al.] // N. Engl. J. Med. - 2005. - Vol. 532. - P. 238-244.

The authors declare that there are no conflicts of interest present.